StartupsFinSMEsabout 2 hours ago
Memento Medicines Raises $93M in Series A Funding
1 min read
Memento Medicines raised $93 million in Series A funding. The round supports the company's development of precision medicines for neurodegenerative diseases. The financing represents one of the larger early-stage rounds in the biotech sector this year.
Level
Hype check
Tap to vote and see what everyone thinks.
